JPH0251548B2 - - Google Patents

Info

Publication number
JPH0251548B2
JPH0251548B2 JP58230486A JP23048683A JPH0251548B2 JP H0251548 B2 JPH0251548 B2 JP H0251548B2 JP 58230486 A JP58230486 A JP 58230486A JP 23048683 A JP23048683 A JP 23048683A JP H0251548 B2 JPH0251548 B2 JP H0251548B2
Authority
JP
Japan
Prior art keywords
acid
solid
melting point
imidazolidine
spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58230486A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59116274A (ja
Inventor
Andoryuu Ripinsukii Kurisutofuaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS59116274A publication Critical patent/JPS59116274A/ja
Publication of JPH0251548B2 publication Critical patent/JPH0251548B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP23048683A 1982-12-06 1983-12-06 糖尿病合併症治療用のスピロ−３−ヘテロ−アゾロン Granted JPS59116274A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44733782A 1982-12-06 1982-12-06
US447337 1982-12-06
US545450 1983-10-28

Publications (2)

Publication Number Publication Date
JPS59116274A JPS59116274A (ja) 1984-07-05
JPH0251548B2 true JPH0251548B2 (cs) 1990-11-07

Family

ID=23775964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23048683A Granted JPS59116274A (ja) 1982-12-06 1983-12-06 糖尿病合併症治療用のスピロ−３−ヘテロ−アゾロン

Country Status (7)

Country Link
JP (1) JPS59116274A (cs)
CS (1) CS244683B2 (cs)
DD (1) DD234265A5 (cs)
HU (1) HU193191B (cs)
IN (1) IN160449B (cs)
SU (1) SU1380610A3 (cs)
ZA (1) ZA839023B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
PL2444085T3 (pl) * 2005-05-13 2015-07-31 Univ California Związki diarylohydantoinowe jako antagoniści receptora androgenów do leczenia raka

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives

Also Published As

Publication number Publication date
CS244683B2 (en) 1986-08-14
HU193191B (en) 1987-08-28
CS913083A2 (en) 1985-09-17
SU1380610A3 (ru) 1988-03-07
ZA839023B (en) 1985-07-31
IN160449B (cs) 1987-07-11
DD234265A5 (de) 1986-03-26
JPS59116274A (ja) 1984-07-05

Similar Documents

Publication Publication Date Title
DE60206454T2 (de) Difluormethylen aromatische Ether und ihre Verwendung als Inhibitoren des Glycin-Typ-1-Transporters
JPS6237636B2 (cs)
CH653684A5 (fr) Derives de carbostyrile, procede pour leur preparation et compositions les contenant.
US5455248A (en) Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof
EP0115133B1 (en) Spiro-3-hetero-azolones for treatment of diabetic complications
JPS63253086A (ja) 偏光性ヒダントイン類
JPH0251548B2 (cs)
JPS6049183B2 (ja) ２−アミノメチルフェノ−ル誘導体
FR2510110A1 (cs)
Jones et al. Reactions of 1, 4-quinone N, N'-dibenzenesulfonylimines, 1, 4-quinones, and 1, 4-quinone N, N'-dibenzoylimines with secondary diazo compounds. Structures of alleged arocyclopropenes
EP0159143B1 (en) Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4705807A (en) Amine derivatives
US4474967A (en) 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
EP0127412A2 (en) Imidazolidinedione derivatives
JPS6137768A (ja) １，３‐二置換ピペリジン化合物
US3754090A (en) Pharmaceutical compositions and methods for substituted phenethyl alcohols and their esters
DE69101937T2 (de) Antiallergische und antiinflammatorische Mittel auf der Basis von Benzoquinon.
Baker et al. AN ANTIMALARIAL ALKALOID FROM HYDRANGEA. VII. 3-[β-KETO-γ-(5-HYDROXY-2-PIPERIDYL) PROPYL]-4-QUINAZOLONE, AN ISOMER
US2911409A (en) 2-spiro-substituted pyrrolidines
JPS6229428B2 (cs)
Buckle et al. Hydroaromatic analogs of 2-nitro-1, 3-indandiones
US4423232A (en) Tricyclic isoindole derivatives
US4323572A (en) Antihypertensive tricyclic isoindole derivatives
Leonard et al. Directive Influence of the Acetylamino Group in the Friedel--Crafts Acylation of the Diacetylaminonaphthalenes
JPH11130713A (ja) ジベンゾシクロヘプテノン誘導体及びその塩